A Study of SRP-9005 in Limb Girdle Muscular Dystrophy Type 2C/R5 Pediatric and Adult Participants

NCT06952686 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study was Withdrawn per Sponsor decision.

Conditions

Muscular Dystrophies, Limb-Girdle

Interventions

BIOLOGICAL: SRP-9005
DRUG: Corticosteroid

Sponsor

Sarepta Therapeutics, Inc.